Lulu Zang
Publications by Year
Research Areas
Atherosclerosis and Cardiovascular Diseases, Immune Response and Inflammation, Inflammasome and immune disorders, Immune cells in cancer, NF-κB Signaling Pathways
Most-Cited Works
- → Poria cocos polysaccharides attenuated ox-LDL-induced inflammation and oxidative stress via ERK activated Nrf2/HO-1 signaling pathway and inhibited foam cell formation in VSMCs(2020)96 cited
- → Harmine mitigates LPS-induced acute kidney injury through inhibition of the TLR4-NF-κB/NLRP3 inflammasome signalling pathway in mice(2019)88 cited
- → Poria cocos polysaccharides reduces high‐fat diet‐induced arteriosclerosis in ApoE−/− mice by inhibiting inflammation(2020)54 cited
- → Cinnamaldehyde attenuates atherosclerosis via targeting the IκB/NF-κB signaling pathway in high fat diet-induced ApoE−/− mice(2019)54 cited
- → Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways(2018)49 cited
- → Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway(2019)45 cited
- → Fraxin inhibits lipopolysaccharide‐induced inflammatory cytokines and protects against endotoxic shock in mice(2019)36 cited
- → The inhibitory effect of (−)-Epicatechin gallate on the proliferation and migration of vascular smooth muscle cells weakens and stabilizes atherosclerosis(2020)22 cited
- → Harmine ameliorates CCl4-induced acute liver injury through suppression of autophagy and inflammation(2024)17 cited
- → Tectoridin alleviates lipopolysaccharide-induced inflammation via inhibiting TLR4-NF-κB/NLRP3 signaling in vivo and in vitro(2022)15 cited